SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001753926-23-001555
Filing Date
2023-11-28
Accepted
2023-11-28 17:28:27
Documents
12
Period of Report
2023-11-28
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K g083873_8k.htm   iXBRL 8-K 39536
  Complete submission text file 0001753926-23-001555.txt   215505

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lipo-20231128.xsd EX-101.SCH 3012
3 XBRL LABEL FILE lipo-20231128_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE lipo-20231128_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT g083873_8k_htm.xml XML 3479
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 231447674
SIC: 2834 Pharmaceutical Preparations